(Updated - January 7, 2022 9:01 AM EST)

Stephens analyst Mason Carrico initiates coverage on OncoCyte Corp (NASDAQ: OCX) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE